Loading...

PODCAST

BioTech Nation ... with Dr. Moira Gunn

Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for

science life sciences

All Episodes

18:07

Reengineering Chemotherapy for Solid Tumors...Lew...

BioTech Nation ... with Dr. Moira Gunn ·

2026/09/29

What if chemotherapy could be delivered in a focused way, directly to a tumor, and only where it's needed? Intensity Therapeutics Founder, President, & CEO Lew Bender shares how they're working to change how chemotherapy is delivered to solid tumors, personalized for each patient, with the hopes of reducing the toll it takes on the body.

en

7:52

A New Path Forward for Cell Therapy...Jeff Liter,...

BioTech Nation ... with Dr. Moira Gunn ·

2026/09/22

This week on BioTech Nation, Jeff Liter of Luminary Therapeutics shares how his team is taking a new approach to advanced cell therapy, in the hopes of making it more accessible and affordable. Rather than formulating a custom treatment using a patient's own cells, they use healthy donor cells that are ready to go. This approach could help more people get treated for cancer and autoimmune diseases like lupus, with just a single dose.

en

40:07

Paving the Way for Miracle Drugs...Barry Werth,...

BioTech Nation ... with Dr. Moira Gunn ·

2026/09/15

On this episode of Biotech Nation...the story of how the United States' pharmaceutical industry came to be, and the people behind it all. Barry Werth joins Moira to discuss his new book, “The Age of Cures: How American Scientists Saved Your Life", about a handful of individuals who revolutionized research and helped build the drug development ecosystem we have today.

en

14:52

A Different Approach to Treating Gout...Dr. James...

BioTech Nation ... with Dr. Moira Gunn ·

2026/09/08

On this episode of BioTech Nation...Dr. James Mackay joins to talk about the progress Crystalys Therapeutics is making in the treatment of gout - a disease that affects more than 13 million people in the United States alone. Dr. Mackay debunks some common misconceptions surrounding the disease, and explains what Crystalys is doing to change the way doctors treat gout going forward.

en

20:08

The Potential of Peptide Drugs...Dr. Karsten Eastman,...

BioTech Nation ... with Dr. Moira Gunn ·

2026/09/01

You've probably heard of Peptides...but what exactly are they? And how do we know which ones are effective, and safe? Dr. Karsten Eastman, Co-Founder and CEO of Sethera Therapeutics, joins to answer all our questions about Peptides, and to tell us about Sethera's latest efforts to enhance peptides to make new medicines. Their plan: to develop a drug using enhanced peptides for Triple-Negative Breast Cancer... and they've already received funding.

en

13:42

Injectable Ice for Chronic Pain? Sameer Sabir,...

BioTech Nation ... with Dr. Moira Gunn ·

2026/08/25

This week on BioTech Nation, Sameer Sabir, CEO of Brixton Biosciences, shares how their breakthrough injectable cold therapy, Neural Ice, could offer lasting relief for osteoarthritis pain. With a drug-free, nerve-targeting approach currently in clinical trials, this innovation may change how we treat joint pain without pills or repeated steroid injections.

en

14:23

Healing Hard-to-treat Wounds Faster?? Dr. Ned...

BioTech Nation ... with Dr. Moira Gunn ·

2026/08/18

Imagine a world where the toughest wounds heal twice as fast, and patients get their lives back sooner than anyone thought possible. Dr. Ned Swanson, the President and Chief Medical Officer of Polarity Bio, tells us about their approach to healing serious, hard-to-treat skin wounds. In early trials, it's twice as effective as the current treatment for diabetic foot ulcers.

en

23:18

Stem Cell Therapy for Congenital Heart Defects...Dr....

BioTech Nation ... with Dr. Moira Gunn ·

2026/08/11

Can you imagine parents expecting a baby, going in for an ultrasound, and finding out that their baby is missing the heart's left ventricle? This week on BioTech Nation, we hear Dr. Joshua Hare, Co-Founder and Chief Scientific Officer of Longeveron, talk about how they are testing the use of stem cells to treat babies born with a serious congenital heart defect.

en

16:43

Managing Pain While Fighting Cancer...Dr. Lorin...

BioTech Nation ... with Dr. Moira Gunn ·

2026/08/04

This week on BioTech Nation, we explore a new approach to cancer treatment that could help patients manage pain without compromising their care. Dr. Lorin Johnson, CSO of Glycyx Therapeutics explains how a new once-daily pill could help patients manage pain without blocking their treatment.

en

18:44

A New Kind of Flu Shot...Dr. Jeff Stein, President &...

BioTech Nation ... with Dr. Moira Gunn ·

2026/07/28

This week on BioTech Nation, Dr. Jeff Stein, President & CEO of Cidara Therapeutics, brings up promising news about a new approach to flu shots.

en

14:18

Insulin-Producing Cells...with no...

BioTech Nation ... with Dr. Moira Gunn ·

2026/07/14

This week on BioTech Nation, Dr. Steve Harr, CEO of Sana Biotechnology, talks about their progress in Type I diabetics, in particular. The New England Journal of Medicine publishes early success with Sana Biotechnology's engineered insulin-producing cells without the need for immunosuppressant drugs.

en

48:19

Looking Forward: Biotech in the Balance? Dr. Jeremy...

BioTech Nation ... with Dr. Moira Gunn ·

2026/06/21

On this episode of BioTech Nation...The Biotech landscape is ever-evolving - but where are we headed?? Dr. Jeremy Levin, Physician, Bioentrepreneur, and Former Chair of BIO, joins Moira to talk about the future of Biotech from the front lines of the industry - from understanding the global Bioeconomy, to preparing for the next pandemic, and how government policy is impacting innovation. His book is, "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust".

en

34:14

How 200 Snake Bites Became an Antivenom...Dr. Jake...

BioTech Nation ... with Dr. Moira Gunn ·

2026/06/16

This week on BioTech Nation, a call to a man who survived hundreds of venomous snake bites helps inspire the development of an antivenom vaccine. Biotech Entrepreneur, Dr. Jake Glanville, Founder, Chair and CEO of Centivax, gives us the insider’s view of this Biotech Breakthrough – from the first telephone call through each significant step, all leading to the first breakthrough generalized antivenom vaccine in 125 years.

en

7:55

Hospital at Home? Dr. Daniel Kraft, Tech Nation...

BioTech Nation ... with Dr. Moira Gunn ·

2026/06/09

On this week's BioTech Nation, Tech Nation Health Chief Correspondent Dr. Daniel Kraft tells us about the trend of "hospital-at-home". As we see the expansion of remote healthcare technologies, could the future of hospital-like care be as on-demand as a food delivery app?

en

24:43

Personalized Vaccines for Treating Glioblastoma? Jay...

BioTech Nation ... with Dr. Moira Gunn ·

2026/05/29

In time for the 2026 ASCO Annual Meeting in Chicago, we're highlighting 3 BioTech companies shaping the future of cancer treatment...On this episode of BioTech Nation, Dr. Will Decker and Jay Hartenbach join Moira to talk about Diakonos Oncology's unique approach to cancer immunotherapy. 25 years ago, as a young post-doc, Dr. Decker made a discovery that wasn't in the biology textbooks - and the scientific community was skeptical. But now, after two decades of research and a new drug

en

13:11

Two Drug Approvals in Two Years...Michael Metzger,...

BioTech Nation ... with Dr. Moira Gunn ·

2026/05/28

In time for the 2026 ASCO Annual Meeting in Chicago, we're highlighting 3 BioTech companies shaping the future of cancer treatment...On this episode of BioTech Nation: how Syndax Pharmaceuticals got two new drugs approved in the last two years, for the treatment of acute myeloid leukemia and graft vs. host disease in both adults and children. CEO Michael Metzger talks to Moira about Syndax's approach to getting the drugs across the finish line, and how they've now set their sights on

en

16:37

Fighting Hard-to-Treat Cancers...Dan Schmitt,...

BioTech Nation ... with Dr. Moira Gunn ·

2026/05/26

In time for the 2026 ASCO Annual Meeting in Chicago, we're highlighting 3 BioTech companies shaping the future of cancer treatment:On this episode of BioTech Nation, Dan Schmitt of Actuate Therapeutics talks about a new kind of drug showing positive early results in hard-to-treat cancer - including adult pancreatic cancer, and two pediatric cancers. So, what’s next? Global collaborations, international trials, and efforts into different types of cancer…and they’re showing no sign of slowing

en

13:14

A Different Way to Treat Parkinson's...Dr. Jonas...

BioTech Nation ... with Dr. Moira Gunn ·

2026/05/19

This week on BioTech Nation, Dr. Jonas Hannestad and Dr. Joanne Taylor of Gain Therapeutics join Moira to discuss a different approach to treating Parkinson's. While treatments are typically focused on relieving symptoms, Gain Therapeutics aims to stop progression of the disease itself.

en

17:32

A Life Decoded...A 2007 Interview with Dr. J. Craig...

BioTech Nation ... with Dr. Moira Gunn ·

2026/05/12

With the recent passing of Dr. J. Craig Venter, biotech scientist and entrepreneur, we look back at Moira and David Ewing Duncan's 2007 interview with Dr. Venter. The occasion for the interview was the publication of his autobiography: "A Life Decoded: My Genome, My Life." Dr. Craig Venter was known for catalyzing the race to decode the human genome, and at the time of the interview had just decoded his own complete DNA and published it on the Internet.

en

32:39

50 Years of Genentech...Ashley Magargee, CEO, Genentech

BioTech Nation ... with Dr. Moira Gunn ·

2026/05/05

This week on BioTech Nation, we celebrate the 50th anniversary of Genentech, the first biotech company to go public. Moira speaks with CEO Ashley Magargee about the company's journey over the last 50 years, the evolution of biotech, and where they're headed next.

en

187 results

Similar Podcasts

The Deep Dive Lab: Unraveling Materials Science

Son Hoang

New Books in Political Science

New Books Network

Station 151

Pale Matter | Realm

Beyond the Divide

Koala Moon

StarTalk with Neil deGrasse Tyson

Neil deGrasse Tyson